Development of a Transdiagnostic Intervention for Adolescents at Risk for Serious Mental Illness
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age14-19
SponsorMassachusetts General Hospital
About this trial
This research study aims to develop a brief group-based treatment called Resilience Training for Teens, then to test how well it protects high school students with mild symptoms of depression, anxiety, or having unusual feelings from developing mental illnesses.
Eligibility criteria
Qualifiers
Currently enrolled in 9th through 12th grade and between the ages of 14 and 19
Endorsed at least one psychotic experience
Provided contact information
Have a parent or legal guardian who is able and willing to provide written informed consent (if under the age of 18)
Disqualifiers
Currently prescribed psychotropic medication (not including medications for attention deficit/hyperactivity disorder), regardless of adherence
Currently obtaining psychotherapeutic intervention
Trial design
Treatments tested in this trial
- Resilience Training for Teens
Treatment groups
70 Participants
are divided into 2 treatment groupsSponsors and collaborators
Massachusetts General Hospital
Lead sponsor
National Institute of Mental Health (NIMH)
Collaborator
Source ClinicalTrials.gov